Philippe Langella

Research Director, Laboratory of Commensals and Probiotics-Host Interactions, MICALIS Institute, INRA, France
When
11th-12th May 2021
Where
Rotterdam, Netherlands
The 8th Microbiome and Probiotics R&D and Business Collaboration Forum is Europe’s longest-running and largest Microbiome meeting. It has an unrivalled reputation for attracting leading academics to present the newest available discoveries being made about microbiota and human health. With an equal measure of researchers from industry, this outstanding networking meeting was the place to learn, built new partnerships and explore effective business and commercialisation strategies.
Last Year’s Microbiome & Probiotics R&D and Business Collaboration Forum | ||||
Track 1 | Track 2 | Track 3 | Track 4 | |
Day 1 | IBD, Colitis, Metabolic Diseases | Women & Infant Health | Probiotics & Prebiotics and Diagnostics | Skin & Cosmeceuticals |
Day 2 | Gut-Brain Axis and Microbiome Tools & Technologies | Business Collaboration – Regulations & Investment | Personalised Nutrition | Skin & Cosmeceuticals, Cancer and Microbiome Biobanks |
Download the 2020 Agenda
Co-Founder & CEO, Microbiome Insights, Inc., Canada
Vice-President of Business Development EMEA, CSP Technologies
Founder & CEO, ClearSkin
Centre for Human Drug Research, Senior Clinical Scientist
Assistant Professor of Cancer Epidemiology, UCD Conway Institute, University College Dublin, Ireland
Consultant & former CEO, Unibiome
Head of Process Development and Support, Cobra Biologics
Elizabeth Blackwell Institute Research Fellow in Integrative Epidemiology, University of Bristol, UK
Specialist Obstetrics and Gynecology, Senior consultant of San PIO X Hospital Milan, Italy
Nutritional Scientist, Team Science, Department Research and Development, HiPP
Customer Success Associate, Zymo Biomics
Director Process R&D, Oxthera, Sweden
Vice President Growth Fields; Evonik Operations GmbH, BL Care Solutions
Co-Founder, The Gut Stuff
Lecturer in Nutritional Sciences, University of Southampton
Senior Lecturer, Department of Plant Pathology and Microbiology, Hebrew University, Israel
Head of Preclinical Research, EverImmune
Senior Research Advisor, Bioeconomy – Research and Competitive Funding Division, Alma Mater Studiorum Università di Bologna, Italy
Assistant Professor, Centre for Antibiotic Resistance Research, Institute of Biomedicine, University of Gothenburg, Sweden
Group Leader, Quadram Institute
Research Scientist, IPLA-CSIC
Regulatory project Manager / Primary Reviewer, Office of Vaccines Research and Review Center for Biologics Evaluation and Research, U. S. Food and Drug Administration
Distinguished Scientist and Group Leader, Systems Genetics, Oak Ridge National Laboratory
Scientist, R&D Microbiome, DNA Genotek
R&D Skin Care, DSM
Technology Scout – Skin’, Walgreen Boots Alliance
R&D Project Leader, BASF
Head, Business Development, Biose Industrie
General Manager, Business Development, Luina Bio
Bioinformatics engineer, Life and Soft
Director of Scientific Operations, Clinical Microbiomics
Senior Business Development Manager, Labskin
Microbiome Scientist, DayTwo
Chief Scientific Officer,SolnulTM Prebiotic Resistant Starch, Canada
Data Scientist, Biofortis Merieux NutriSciences
Business Development Manager, Nizo
Group Leader Fermentation, Nizo
Chief Scientific Officer, Biofortis Merieux NutriSciences
Regulatory Manager, Cosmetic Ingredients, DSM
Research Project Development Manager, MGI Tech/ BGI Research
Executive Director, Nutrition+HealthCARE
NGS Senior Specialist, Givaudan
Professor of Pharmaceutical Technologies, University of Greenwich, Visiting Professor, Department of Surgery and Cancer, Imperial College
CSO, Da Volterra
Senior Scientist, Corporate Microbiology Group, Henkel
Senior Research Co-ordinator and APC Faculty Investigator, APC Microbiome Ireland
Co-Founder, The Gut Stuff
Associate Professor, Medical University of Vienna
Senior Scientist, Probi AB
Research Scientist, Walgreen Boots Alliance
Chief Medical Officer, Openbiome, USA
Senior Principal Investigator, Skin Research Institute Singapore; Professor, Medical University of South Carolina
CSO, LNC Therapeutics
Assistant Professor, Department of Dermatology, University of Iowa, USA
Vice Chair and Head, Consultant Dermatology, Erasmus University Medical Centre, Netherlands
Sales Director, Novogene
Associate, Sterne, Kessler, Goldstein & Fox P.L.L.C
Regulatory Consultant, Food Observatory
Professor in Neuro-immunopharmacology, Utrecht University, the Netherlands
Professor of Translational Dermatology, University of Manchester and CSO, SkinBiotherapeutics plc.
Founder and CEO, Bio-Me
CSO, Clinical Microbiomics
Senior Manager Science, Yakult Nederland B.V., Associate Professor, Vrije Universiteit Amsterdam
Founder and CEO, ImmuneBiotech AB
CEO, Biomillenia
Professor in Biomedical and Life Sciences, University College Roosevelt, Middelburg and Microvida Laboratory for Medical Microbiology and Immunology, St. Elisabeth Hospital, Tilburg, The Netherlands
President, European Scientific League for Probiotics, Belgium
Professor & Research Leader, Institute of Food Research, UK
Director R&D Alliance Management, Ferring Pharmaceuticals, Switzerland
Associate Professor of Systems Ecology, University of Luxembourg
Scientific Director, L’Oréal Advanced Research, France
Operations Manager, Caelus Health, The Netherlands
Research Director, Laboratory of Commensals and Probiotics-Host Interactions, MICALIS Institute, INRA, France
Founder, Gallinée, UK
Partner, Seventure Partners
Vice President of Product, CosmosID
CSO, Yun Probiotherapy, Belgium
Professor Obstetrics and Gynecology, Catholic University, Rome, Italy
Professor, Microbiology & Immunology & Computer Science, Virginia Commonwealth University
CEO, Lactobio
Founder and CEO, Juno Bio
CEO and Founder of REM Analytics
CEO, Carbiotix
CEO, Human Microbiology Institute
Consultant Gastroenterologist, S.Raffaele Hospital, Adjunct Professor of Gastroenterology, S.Raffaele University, Milan, Italy
Academy of Finland Research Fellow, Adjunct professor, University of Jyväskylä
R&D Manager, Nutrition & Biosciences, DuPont
CEO and Founder, Beo Therapeutics
Chief Scientific Officer, SolnulTM Prebiotic Resistant Starch
CEO, Phi Therapeutics, USA
Research Director, Microbiome Biobank, University of Turku, Finland
CEO, TargEDys, France
CEO, Institut Allergosan
Co-Founder & CSO, GNUbiotics Sciences
Chief Executive, CHAIN Biotechnology Ltd
Global Vice President Unilever Skin Care R&D, Divisional Head Prestige R&D, Head of North America R&D Campus, Unilever
CEO, Postbiotics Plus
CEO, Biosortia Pharmaceuticals
Co-Founder, S-Biomedic, Belgium
CTO and Head of Operations, Genetic Analysis AS, Norway
Chief Science Officer, Viome, USA
Associate Professor, Medical University of Vienna
Co-Founder & CEO, Microbiome Insights, Inc., Canada
Vice-President of Business Development EMEA, CSP Technologies
Founder & CEO, ClearSkin
Centre for Human Drug Research, Senior Clinical Scientist
Assistant Professor of Cancer Epidemiology, UCD Conway Institute, University College Dublin, Ireland
Consultant & former CEO, Unibiome
Head of Process Development and Support, Cobra Biologics
Elizabeth Blackwell Institute Research Fellow in Integrative Epidemiology, University of Bristol, UK
Specialist Obstetrics and Gynecology, Senior consultant of San PIO X Hospital Milan, Italy
Nutritional Scientist, Team Science, Department Research and Development, HiPP
Customer Success Associate, Zymo Biomics
Director Process R&D, Oxthera, Sweden
Vice President Growth Fields; Evonik Operations GmbH, BL Care Solutions
Co-Founder, The Gut Stuff
Lecturer in Nutritional Sciences, University of Southampton
Senior Lecturer, Department of Plant Pathology and Microbiology, Hebrew University, Israel
Head of Preclinical Research, EverImmune
Senior Research Advisor, Bioeconomy – Research and Competitive Funding Division, Alma Mater Studiorum Università di Bologna, Italy
Assistant Professor, Centre for Antibiotic Resistance Research, Institute of Biomedicine, University of Gothenburg, Sweden
Group Leader, Quadram Institute
Research Scientist, IPLA-CSIC
Regulatory project Manager / Primary Reviewer, Office of Vaccines Research and Review Center for Biologics Evaluation and Research, U. S. Food and Drug Administration
Distinguished Scientist and Group Leader, Systems Genetics, Oak Ridge National Laboratory
Scientist, R&D Microbiome, DNA Genotek
R&D Skin Care, DSM
Technology Scout – Skin’, Walgreen Boots Alliance
R&D Project Leader, BASF
Head, Business Development, Biose Industrie
General Manager, Business Development, Luina Bio
Bioinformatics engineer, Life and Soft
Director of Scientific Operations, Clinical Microbiomics
Senior Business Development Manager, Labskin
Microbiome Scientist, DayTwo
Chief Scientific Officer,SolnulTM Prebiotic Resistant Starch, Canada
Data Scientist, Biofortis Merieux NutriSciences
Business Development Manager, Nizo
Group Leader Fermentation, Nizo
Chief Scientific Officer, Biofortis Merieux NutriSciences
Regulatory Manager, Cosmetic Ingredients, DSM
Research Project Development Manager, MGI Tech/ BGI Research
Executive Director, Nutrition+HealthCARE
NGS Senior Specialist, Givaudan
Professor of Pharmaceutical Technologies, University of Greenwich, Visiting Professor, Department of Surgery and Cancer, Imperial College
CSO, Da Volterra
Senior Scientist, Corporate Microbiology Group, Henkel
Senior Research Co-ordinator and APC Faculty Investigator, APC Microbiome Ireland
Co-Founder, The Gut Stuff
Associate Professor, Medical University of Vienna
Senior Scientist, Probi AB
Research Scientist, Walgreen Boots Alliance
Chief Medical Officer, Openbiome, USA
Senior Principal Investigator, Skin Research Institute Singapore; Professor, Medical University of South Carolina
CSO, LNC Therapeutics
Assistant Professor, Department of Dermatology, University of Iowa, USA
Vice Chair and Head, Consultant Dermatology, Erasmus University Medical Centre, Netherlands
Sales Director, Novogene
Associate, Sterne, Kessler, Goldstein & Fox P.L.L.C
Regulatory Consultant, Food Observatory
Professor in Neuro-immunopharmacology, Utrecht University, the Netherlands
Professor of Translational Dermatology, University of Manchester and CSO, SkinBiotherapeutics plc.
Founder and CEO, Bio-Me
CSO, Clinical Microbiomics
Senior Manager Science, Yakult Nederland B.V., Associate Professor, Vrije Universiteit Amsterdam
Founder and CEO, ImmuneBiotech AB
CEO, Biomillenia
Professor in Biomedical and Life Sciences, University College Roosevelt, Middelburg and Microvida Laboratory for Medical Microbiology and Immunology, St. Elisabeth Hospital, Tilburg, The Netherlands
President, European Scientific League for Probiotics, Belgium
Professor & Research Leader, Institute of Food Research, UK
Director R&D Alliance Management, Ferring Pharmaceuticals, Switzerland
Associate Professor of Systems Ecology, University of Luxembourg
Scientific Director, L’Oréal Advanced Research, France
Operations Manager, Caelus Health, The Netherlands
Research Director, Laboratory of Commensals and Probiotics-Host Interactions, MICALIS Institute, INRA, France
Founder, Gallinée, UK
Partner, Seventure Partners
Vice President of Product, CosmosID
CSO, Yun Probiotherapy, Belgium
Professor Obstetrics and Gynecology, Catholic University, Rome, Italy
Professor, Microbiology & Immunology & Computer Science, Virginia Commonwealth University
CEO, Lactobio
Founder and CEO, Juno Bio
CEO and Founder of REM Analytics
CEO, Carbiotix
CEO, Human Microbiology Institute
Consultant Gastroenterologist, S.Raffaele Hospital, Adjunct Professor of Gastroenterology, S.Raffaele University, Milan, Italy
Academy of Finland Research Fellow, Adjunct professor, University of Jyväskylä
R&D Manager, Nutrition & Biosciences, DuPont
CEO and Founder, Beo Therapeutics
Chief Scientific Officer, SolnulTM Prebiotic Resistant Starch
CEO, Phi Therapeutics, USA
Research Director, Microbiome Biobank, University of Turku, Finland
CEO, TargEDys, France
CEO, Institut Allergosan
Co-Founder & CSO, GNUbiotics Sciences
Chief Executive, CHAIN Biotechnology Ltd
Global Vice President Unilever Skin Care R&D, Divisional Head Prestige R&D, Head of North America R&D Campus, Unilever
CEO, Postbiotics Plus
CEO, Biosortia Pharmaceuticals
Co-Founder, S-Biomedic, Belgium
CTO and Head of Operations, Genetic Analysis AS, Norway
Chief Science Officer, Viome, USA
Associate Professor, Medical University of Vienna
Gastrointestinal, neurology, cancer, the vaginal microbiome and more
….
Successful strategies for collaboration
….
Building an intellectual property portfolio
….
Explore funding options
Translation
….
Applications and research
….
Personalised Nutrition
….
Early Life and Infant
Novel research
….
Commercialization
….
Marketing and communication
….
Exploiting the latest research tools and techniques
3 for the price of 2 offer
Discount applied automatically when registering 3 places at once.
Not applicable for solution provider companies or compatible with any other offers or discount codes.
Option 1 – Please phone +44 (0) 1865 671957 ext. 207 and we will take your details over the phone
Option 2 – Please complete the form below to pay online
1,099.00€
Standard registration for those not in the categories below
599.00€
1,499.00€
This fee applies to organisations offering services and/or business & technology solutions and also to business consultants.
Poster presentation sessions are an integral part of this meeting. Your presentation will be displayed in a dedicated area, with the other accepted posters from industry and academic presenters.
We also issue a poster eBook to all attendees containing your full abstract, and you can share your poster as a PDF after the meeting if you desire (optional).
Whether looking for funding, employment opportunities or simply wanting to share your work with a like-minded and focused group, these are an excellent way to join the heart of this congress.
In order to present a poster at the forum, you need to be registered as a delegate.
With a reputation for innovation, COPAN is the leading manufacturer of collection and transport systems in the world. COPAN’s collaborative approach to innovation in pre-analytics has resulted in the original FLOQSwabs™, ESwab™, FecalSwab™ and UTM™, as well as Full Laboratory Automation. COPAN’s collection and systems have been proven to advance the quality of traditional and contemporary microbiology assays. COPAN’s automation includes specimen processing, smart incubation, digital imaging, and strong algorithms for automatic segregation of bacterial cultures.
×Vaiomer offers a unique platform to quantify, sequence and analyze the gut, oral, blood and tissue microbiota, with a unique ability to study low bacterial load samples (human or animal: blood, liver, heart, brain, adipose tissue, muscle, bone marrow, MLN, bile, ascites).
Vaiomer’s vocation is to contribute to the studies of disease mechanisms, in clinical and basic research. Our talented scientists support you from the microbiota study design to the exploitation of your study results.
BaseClear offers high quality DNA / RNA sequencing services and complete bioinformatics solutions since 1993. More than 50 highly educated , experienced specialists are ready to take up your next project. Our team can advise you, both during the project planning stage and implementation of the project regarding sample preparation and the best approach to use. BaseClear has extensive experience with metagenomics and genome analyses projects using Next Generation sequencing technologies such as offered by Oxford Nanopore, Illumina and Pacific Biosciences.
×Quay Pharma is experienced in formulation development and is one of very few companies licensed to provide clinical manufacturing materials containing live bacterial strains being targeted for delivery to, and in the digestive, urogenital, otorhinologic and pulmonary tracts. Understanding the clients dosing requirements for the live biotherapeutic, Quay can prepare a formulation development strategy to bring your live bacterial strain rapidly and effective to First in Man studies aiming to provide a formulation with the best change of clinical.
×CosmosID®, based in Rockville, Maryland, provides solutions unlocking the microbiome. A provider of Next-Generation Sequencing (NGS) Services and Bioinformatics Solutions, CosmosID focuses on microbiome analysis and the rapid identification and characterization of microorganisms for pharmaceutical R&D, molecular diagnostics, public health, food safety, agriculture, and environmental applications.
×Novogene Europe, established in 2014, is a leading NGS service provider and serving over 300 scientific research institutes across more than 30 European countries. Novogene Cambridge Genomic Sequencing Center, its first European sequencing center, relocated to Cambridge Science Park in August 2019 due to rapid business expansion. The Center is now equipped with automatic work stations, multiple NovaSeq 6000, and High-Performance Computing Clusters. Novogene Europe provides comprehensive services and customized solutions for your projects.
×At Clinical Microbiomics we offer ‘full-service’ microbiome analysis covering the entire workflow, from extracting DNA from your study samples, over sequencing to profiling and biostatistics, linking the microbiome to clinical outcomes. For us, full-service means supporting you through your study – from planning to the final report. This includes being available throughout your study, during the analysis and for interpretation and discussions of the results. Our clients come from different research areas, including academic institutions, global pharma, nutrition and biotech companies who are developing microbiome-targeted products.
http://www.clinical-microbiomics.com/
×MGI is committed to building core tools and technology to lead life science through intelligent innovation. MGI focuses on R&D, production and sales of sequencing instruments, reagents, and related products to support life science research, agriculture, precision medicine and healthcare. MGI is a leading producer of clinical high-throughput gene sequencers, and its multi-omics platforms include genetic sequencing, mass spectrometry, medical imaging, and laboratory automation.
×SERVICE
Biofortis, C.R.O. part of Mérieux NutriSciences Group, specializes in the design and conduct of experimental, pre-clinical, and Clinical Research projects for Health, represents a major player in various segments of nutrition: gastroenterology, metabolism, oncology, immunity, etc.
EXPERTISE
As a pioneer, Biofortis has high performance resources and tools for metagenomic analysis to meet the major health challenges in the microbiota field. With a meta-sequencing platform allowing metabolic and physiological exploration thanks to a new generation sequencing platform, Biofortis, can help you with valuable personalized results.
Aptar CSP Technologies is specialized in Active Packaging to protect sensitive drugs and food supplements from moisture and oxygen.
We offer a large variety of flip-top vials, screw-top bottles and pill dispensers incorporating Activ-PolymerTM desiccant in the container itself.
We can integrate Activ-PolymerTM in Blisters and Pouches in order to control relative humidity and residual oxygen to the optimal level for a better storage and longer shelf life of Microbiotic Medicinal Products for all ICH zones.
http://www.csptechnologies.com/
×As one of the leading venture capital firms in Europe, Seventure manages more than €750m at the end of 2018. Since 1997, Seventure has been investing in innovative businesses with high growth potential in Life Sciences in Europe/US/Canada/Israel and Japan
In Life Sciences, Seventure’s preferred fields are:
TNO is a research and technology innovation institute with established capabilities and track record in determining relationships between diet or drugs, gut microbiome and host health. With a suite of advanced technologies we offer comprehensive approaches to address our customers’ questions on product functionality and microbiome related health. These technologies and their applications include i-screen, InTESTine TM (ex vivo technologies), organoids and gut-on-a-chip for in depth in vitro studies.
https://www.tno.nl/en/focus-areas/healthy-living/roadmaps/biomedical-health/microbiome/
×YOUR KEY TO EARLY PHASE MANUFACTURING
Our services provide cost effective manufacturing of your GMP clinical trial material. We offer rapid technology transfer, scale-up development and manufacturing of microbial cell-derived proteins at up to 500L scale for the preparation of active pharmaceutical ingredient (API) products to world class standard to provide a key to your product development success.
Zymo Research has been serving the academic and biopharmaceutical scientific communities by providing DNA and RNA purification products since its inception in 1994. Zymo also provides the first commercially available microbiomics standards for the development, evaluation, calibration, and validation of complex microbiomics workflows encompassing sample collection, sample preparation, and analyses. It is also the first supplier to validate every step of the process using Microbial Community Standards to ensure our tools and services are accurate.
×Life&Soft is a French innovative bioinformatics company founded in 2013. We help R&D, clinical and IS teams from pharmaceutical, cosmetics or diagnostics industry to get the best from their data while integrating their constraints.
Microbiome is at the core of Life&Soft innovation. We develop analysis solutions based on 16S and whole genome sequencing. We recently released a fast and efficient approach using Artificial Intelligence algorithms on Nanopore® sequencing data, reaching highly specific and sensitive results.
×Winclove’s mission is to create long-lasting, sustainable and strategic partnerships. To achieve this, we offer innovative, high-quality and competitive probiotic solutions, as well as in-house scientific expertise and sales, marketing and educational support. The thorough substantiation of our probiotic formulations with scientific and clinical evidence makes them ideal for selling medically endorsed.
×This business unit provides solutions for customers in the personal care, home care and fine fragrance markets. Its extensive portfolio includes aroma ingredients, vitamins and natural bioactives, as well as UV filters, peptides, and polymers. With its competence & expertise in science, formulations, and applications it is well placed to deliver on diverse consumer beauty and health needs, especially in the context of aging populations and increasing ethnic & cultural requirements. The business also addresses the public health issue of globally rising skin cancer rates, providing innovative sun care solutions that extend beyond UV into the blue light range, and creating and creating awareness of the need to use sun protection daily.
×Probi is a world leader within probiotics – dedicated to probiotics only. Our vision is to contribute to healthier life by delivering effective and well-documented probiotics, with proven health benefits based on scientific research. Probi offers probiotic expertise and partnership all the way from R&D to finished products for companies within the consumer healthcare and food industry. Probi manufacturing is GMP certified and produces proven probiotics in custom made formats with value-adding delivery technologies.
×Bio-Me is transforming microbiome analysis by making it possible to analyze hundreds of samples in less than a day, with high resolution and reproducibility and at an affordable cost. Combined with an exclusive biobank and extensive patient database, Bio-Me’s Precision Microbiome Profiling platform (PMP™) enables the development of clinical tests that will improve health and well-being worldwide.
×Givaudan Active Beauty offers an extensive portfolio of innovative active cosmetic ingredients designed to bring beauty to the world. Inspired by the beauty needs of consumers, Active Beauty offers award-winning products for an expanded range of benefits. Our cutting-edge technologies draw on science and nature to create high-performing molecules and functional agents, including customised carrier systems. Active Beauty leads the market in crafting innovative products supported by our strong expertise in advanced and applied sciences
https://www.givaudan.com/fragrances/active-beauty
×The BioLector® microbioreactor enhances bioprocess development and microbial screening efforts. Researchers can conduct bioprocess scale-up experiments (aerobic / microaerophilic / strict anaerobic) with high efficiency and excellent data quality, at micro-scale costs. The system utilizes a shaken microtiter plate (MTP) providing high-throughput and on-line measurements of: DO, biomass, pH and fluorescence. The combination of high-throughput and high information content makes the BioLector® system an invaluable tool for any microbial or microbiome bioprocess development laboratory.
×ProDigest is a preclinical CRO with a unique in vitro gut simulation technology, the SHIME®. We help food and pharma customers understand the mechanism of action of their products along the GI tract and the interplay with the gut microbiome.
ProDigest’s expertise covers drug stability, strain survival, compound metabolisation, gut microbiota impact and host-microbiota interaction. Each project is customised to optimise the experimental design to the customer’s needs and budget.
×MetaGenoPolis (MGP) is the INRA center of metagenomic in human and animal microbiome research. In collaboration with industries, academies and clinics, MGP conceives and implements projects tailored to the partner’s need. ISO 9001 certified, the protocols and procedures implemented are constantly kept at the cutting edge of technology. MGP proposes quantitative and functional metagenomic to analyse complex microbiome diversity and interactions between gut bacteria and human cells.
×The Quadram Institute’s mission is to deliver healthier lives through innovation in gut health, microbiology and food. We bring together researchers and clinicians in a unique environment where interdisciplinary collaboration and innovation address global health challenges.
Focusing on how the microbiome contributes to lifelong health we aim to understand how food and microbes interact to promote health and prevent disease, and to use this knowledge to develop new probiotics, pharmaceuticals or microbial therapies.
×
MyMicrobiome – 2 women from Bavaria, Germany elucidate the world about the microbiome. The internet platform www.MyMicrobiome.info explains the science behind the future topic microbiome, clearly and comprehensively for the layman. In addition, we have developed the world’s first and only quality standard for microbiome-friendly cosmetics and personal care products, followed by a quality standard for probiotics in nutrition.
×Select which delegates you would like to meet in a series of prearranged twenty-minute one-to-one meetings. Receive advanced delegate list from which to choose whom you’d like to meet with. Global Engage will schedule these meetings and send you an itinerary before the event
Host your own half or full day pre or post event workshop to a dedicated audience around a subject of your choice. Global Engage will assist with the marketing of your workshop to provide a guaranteed audience.
Market to our event database and / or increase brand awareness by taking a poster position or sponsoring the poster sessions. This can be supplemented by branding options such as placing your logo on the meeting background screen.
Showcase your technologies and products throughout the conference in the dedicated exhibition areas where all refreshment breaks and lunches take place, as well as the networking drinks reception at the end of day one.
Options include:
For further details please contact
Gavin Hambrook, Conference Director
Telephone +44 (0) 1865 849841 or
email [email protected]
Start receiving your free copy today. American Pharmaceutical Review is a journal covering the drug pipeline from the late discovery phase through manufacturing. American Pharmaceutical Review prides itself on having the most relevant, unbiased and informative editorial in the industry. You will find that all of our editorial is highly technical and written by government agencies, consultants, academics, and large pharmaceuticals companies. American Pharmaceutical Review covers several key topics that are important to drug production:
Biomall.in is an online e-commerce marketplace that ships lab reagents, lab equipment & supplies worldwide. Visit Biomall.in now to buy laboratory, life science & diagnostic products from India.
×BioVox is a specialized life sciences news and communication platform keeping you up to date on the rapidly evolving life sciences sector in Belgium and on global scientific and industry trends. BioVox brings exclusive news, in-depth interviews, opinions, and insights on healthcare, agriculture and the bio-based economy.
×BlueSEQ Partners is a specialized global consulting firm focused on the Life Sciences, Digital Biology, and Genomics markets. Their unique blend of Business Management, Technology Understanding, and Strategy and Execution capabilities is what separates them from other consulting firms.
The BlueSEQ Partners group offers customized consulting teams to help their clients gain access to relevant industry C-level expertise, which many of their consultants have achieved over many years’ worth of successful management and scientific operations.
×Cardea Bio is developing a new generation of (bio)technology infrastructure based on proprietary biology-gated transistors (“Cardean transistors”). Cardean transistors leverage biocompatible graphene instead of silicon and replace optical signal observations with direct electrical molecular signal analysis. Until now, life science data was comprised of static snapshot datasets. With Cardean transistors, the company and its Innovation Partners can generate streaming multi-omics data to measure real-time biological signals. Cardea is now manufacturing chips at scale and partners have started to significantly expand the amount, type and quality of biological data they capture by building products that Conduct Biology™.
×Global Information, Inc. is an information service company holding offices in 6 countries and have sales agency contracts with over 300 research companies around the world. We sell 30,000 market research reports published by these publishers and accept custom-made researches.
×Insight Pharma Reports are written by experts in consulting and industry who collaborate with us to provide a series of reports that evaluate the salient issues in pharmaceutical technology, business, and therapy markets. Insight Pharma Reports are used by leading pharmaceutical, biotech, diagnostic, consulting, and financial companies to keep abreast of the latest advances in pharmaceutical R&D, their potential applications and business impacts, and their current and future position in the marketplace.
×Labiotech.eu is the leading digital media covering the European biotech industry. Over 150,000 monthly visitors use it to keep an eye on the business and innovations in biotechnology. The company’s mission is to build the “Next Generation of Digital Media for Biotech”.
×Pharma Journalist is a paramount B2b online magazine platform exhibiting targeted and succinct information concerning the world of Pharmaceutical Industry, keeping a tab on the updated and latest updates and trends concerning the field.
×PharmaVOICE magazine provides readers with insightful and thought-provoking commentary about the challenges and trends impacting the life-sciences industry in a multiple-perspective format through articles covering a range of issues from molecule through market. PharmaVOICE’s more than 41,000 BPA-qualified subscribers are also kept abreast of the latest trends and information through additional media resources, including WebLinx Interactive WebSeminars, Podcasts, Videocasts, White Papers, E-Surveys and e-Alerts.
×rapidmicrobiology.com is a well-established on-line resource for microbiologists worldwide. Find the right products for your microbiology lab using our specially designed search functions. Keep up-to-date with the latest microbiology news. Get our free weekly newsletter which includes updates on products, services, webinars, training courses and conferences.
×World Pharma Today is a leading Magazine featuring latest industry developments for the Pharmaceutical C-level executives.
×Call us on +44 (0)1865 849 841
For details on attendees, packages and new opportunities, please contact our sponsorship team who will quickly provide everything you need to assess the conference for yourself.